华北制药: 2024年年度股东大会决议公告

Meeting Details - The shareholders' meeting was held on June 11, 2025, at the company's office in Shijiazhuang Economic and Technological Development Zone [1] - The meeting was conducted with a combination of on-site and online voting, presided over by Mr. Wang Lixin [1] Attendance - The meeting had a high attendance rate, with A-share shareholders voting overwhelmingly in favor of the proposals [2][3] - Notable absences included Mr. Yao and Mr. Song Rentao due to work commitments [1] Voting Results - All proposed resolutions were passed with significant majority votes, with A-share approval rates ranging from 98.5382% to 99.8745% across various resolutions [2][3][4] - Specific voting results included: - 995,003,518 votes in favor (99.8745%) for one resolution [2] - 994,993,318 votes in favor (99.8734%) for another resolution [2] - 981,690,456 votes in favor (98.5382%) for a different resolution [3] Resolutions Passed - The meeting approved several key resolutions, including: - Company guarantee matters [4] - Daily related party transactions [4] - Appointment of the auditing firm for the year 2025 [4] - Financial service agreements with Jizhong Energy Group [4] - Anticipated financial business and related transactions for the year [4] Legal Compliance - The meeting's procedures, attendance, and voting were confirmed to comply with relevant laws and regulations, ensuring the legality and validity of the resolutions passed [4]